These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27825573)

  • 1. Subacute thyroiditis in psoriatic arthritis treated by adalimumab.
    Senlis M; Ottaviani S; Gardette A; Palazzo E; Coustet B; Dieudé P
    Joint Bone Spine; 2017 Dec; 84(6):745-746. PubMed ID: 27825573
    [No Abstract]   [Full Text] [Related]  

  • 2. Subacute thyroiditis in a patient with psoriasis treated with a tumor necrosis factor-α inhibitor.
    Wei YA; Chuang WC; Hong CH
    Int J Dermatol; 2018 Jul; 57(7):869-871. PubMed ID: 29460956
    [No Abstract]   [Full Text] [Related]  

  • 3. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.
    Gladman DD; Mease PJ; Ritchlin CT; Choy EH; Sharp JT; Ory PA; Perdok RJ; Sasso EH
    Arthritis Rheum; 2007 Feb; 56(2):476-88. PubMed ID: 17265483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subacute thyroiditis in a patient with psoriatic arthritis switched from secukinumab to adalimumab: a case report and literature review.
    Nakagawa J; Fujikawa K; Akagi M; Nakaji K; Yasui J; Hanatani Y; Hara T; Mizokami A; Kawakami A
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):36-39. PubMed ID: 32731788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus subacute thyroiditis in a patient treated by infliximab for psoriatic arthritis.
    André R; Opris A; Costantino F; Hayem G; Breban M
    Joint Bone Spine; 2016 Jan; 83(1):109-10. PubMed ID: 26184533
    [No Abstract]   [Full Text] [Related]  

  • 6. Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis.
    Bongiorno MR; Pistone G; Doukaki S; Aricò M
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S15-20. PubMed ID: 18837728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriatic arthritis.
    Durham LE; Taams LS; Kirkham BW
    Br J Hosp Med (Lond); 2016 Jul; 77(7):C102-8. PubMed ID: 27388392
    [No Abstract]   [Full Text] [Related]  

  • 8. Adalimumab for the treatment of severe psoriasis and psoriatic arthritis.
    Papoutsaki M; Costanzo A; Chimenti MS; Chimenti S
    Expert Opin Biol Ther; 2008 Mar; 8(3):363-70. PubMed ID: 18294106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials.
    Mease PJ; Signorovitch J; Yu AP; Wu EQ; Gupta SR; Bao Y; Mulani PM
    Dermatology; 2010; 220(1):1-7. PubMed ID: 19940437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of adalimumab-induced paradoxical psoriatic arthritis with risankizumab.
    Watabe D; Amano H
    Eur J Dermatol; 2020 Oct; 30(5):611-612. PubMed ID: 33185535
    [No Abstract]   [Full Text] [Related]  

  • 12. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
    Perrotta FM; Marchesoni A; Lubrano E
    J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of palmoplantar pustular psoriasis with brodalumab.
    Nakao M; Asano Y; Kamata M; Yoshizaki A; Sato S
    Eur J Dermatol; 2018 Aug; 28(4):538-539. PubMed ID: 30129522
    [No Abstract]   [Full Text] [Related]  

  • 14. Adalimumab: in psoriatic arthritis.
    Simpson D; Scott LJ
    Drugs; 2006; 66(11):1487-96; discussion 1497-9. PubMed ID: 16906782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a preliminary US power Doppler composite score for monitoring treatment in PsA.
    Gutierrez M; Di Geso L; Salaffi F; Bertolazzi C; Tardella M; Filosa G; Filippucci E; Grassi W
    Rheumatology (Oxford); 2012 Jul; 51(7):1261-8. PubMed ID: 22378715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.
    Chew AL; Bennett A; Smith CH; Barker J; Kirkham B
    Br J Dermatol; 2004 Aug; 151(2):492-6. PubMed ID: 15327561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
    Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
    Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The therapeutic benefits of systemic treatment of psoriatic arthritis? The example of golimumab in psoriatic arthritis].
    Boulinguez S; Sibilia J
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H11-5. PubMed ID: 21703459
    [No Abstract]   [Full Text] [Related]  

  • 19. Values of body mass index (BMI) and body surface area (BSA) in patients with psoriatic arthritis treated with adalimumab: Preliminary report.
    Wcisło-Dziadecka D; Kaźmierczak A; Grabarek B; Adamczyk K; Brzoza Z
    Dermatol Ther; 2018 Sep; 31(5):e12680. PubMed ID: 30175494
    [No Abstract]   [Full Text] [Related]  

  • 20. Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab.
    Borrás-Blasco J; Gracia-Perez A; Nuñez-Cornejo C; Rosique-Robles JD; Mateu-Puchades A; Casterá MD; Rubio-Fabra M
    J Clin Pharm Ther; 2008 Jun; 33(3):321-5. PubMed ID: 18452420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.